跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 668 条关于
“Vykat XR”
全部
668
临床试验
510
药物
95
机构
4
资讯
59
8个月前
Soleno Therapeutics Publishes Pivotal VYKAT XR Study Results in Leading Endocrinology Journal
去年
FDA Approves First Treatment for Hyperphagia in Prader-Willi Syndrome
上个月
Neurocrine's Vykat XR Linked to Patient Deaths and Serious Adverse Events in Prader-Willi Syndrome
5个月前
Neurocrine Biosciences Acquires Soleno Therapeutics for $2.9 Billion, Adding First-in-Class PWS Treatment
去年
Soleno Therapeutics Raises $200 Million to Fund Commercialization of First FDA-Approved Prader-Willi Syndrome Therapy
去年
FDA Approves First Treatment for Insatiable Hunger in Prader-Willi Syndrome
8个月前
Soleno Therapeutics Reports Strong Commercial Launch Progress for VYKAT XR in Prader-Willi Syndrome
6个月前
Soleno Therapeutics Faces Class Action Lawsuit Over Alleged Clinical Trial Integrity Issues for Prader-Willi Syndrome Drug
去年
Vivo Capital Secures $740 Million for Third Cycle of Healthcare Investment Fund
8个月前
Rhythm Pharmaceuticals Faces FDA Delay for Setmelanotide in Hypothalamic Obesity as Stock Retreats from 2025 Highs
第 1 页,共 6 页
上一页
下一页